Option Care Health (OPCH) Stock Analysis & AI Equity Report

Medical - Care Facilities USD Explore free reports

Option Care Health (OPCH) overview

Option Care Health (OPCH) stock analysis and AI equity research. For financial year 2025, Valuatum's model shows revenue of USD 5,650m and operating profit of USD 338m; the year-end share price was 31.86 USD and market capitalisation was USD 4,997m. Option Care Health is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get Option Care Health's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueUSD 1,326mFY 2025
Share price31.86 USDFY 2025 year end
RevenueUSD 5,650mFY 2025
Operating profitUSD 338mFY 2025
Net earningsUSD 208mFY 2025
Market capitalisationUSD 4,997mFY 2025 year end

About Option Care Health

Option Care Health provides infusion therapy at patients’ homes and alternate sites, including ambulatory infusion suites. Its services include clinical management, nursing support, care coordination, counseling, monitoring and reimbursement assistance. The company supplies intravenous pharmaceuticals and compounded solutions for anti-infective, nutrition, immunoglobulin and other acute and chronic therapies. It works with patients, physicians, hospitals, managed care organizations, payers and pharmaceutical manufacturers.

Generate the Option Care Health report

Option Care Health is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, usually within an hour

Sources & methodology

Financial figures are sourced from Valuatum's financial model for Option Care Health and represent financial year 2025. See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on Option Care Health

Each report here is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by a score out of five: what other analysts felt the work added over the engine's default report.